<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02089074</url>
  </required_header>
  <id_info>
    <org_study_id>2012/1224a</org_study_id>
    <nct_id>NCT02089074</nct_id>
  </id_info>
  <brief_title>Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack</brief_title>
  <official_title>Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack: Adherence and Cardiovascular Events in the First Three Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helse Midt-Norge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sykehusapotekene i Midt Norge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of drugs is an important factor in secondary prophylaxis after transient ischemic attack
      (TIA), but studies show that adherence to the prescribed drugs is often poor. This randomised
      controlled trial aims to investigate whether a systematic follow up of drug treatment using
      medication reconciliation, medication reviews and patient counselling by clinical
      pharmacists, improves adherence and/or decreases cardiovascular events the first three months
      and the first year after TIA. Patient satisfaction will also be compared between the two
      groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2012</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>adherence to drug treatment in secondary prevention after TIA</measure>
    <time_frame>3 months</time_frame>
    <description>self reporting of adherence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adherence to drug treatment in secondary prevention after TIA</measure>
    <time_frame>1 year</time_frame>
    <description>self reporting of adherence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistence</measure>
    <time_frame>3 months</time_frame>
    <description>Persistence measured by control of filled prescriptions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stroke and cardiovascular events and deaths</measure>
    <time_frame>3 months</time_frame>
    <description>Measured by using data from national health registries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>degree of disability or dependence in the daily activities</measure>
    <time_frame>3 months</time_frame>
    <description>measured by modified Rankin Scale and indirectly by level of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>3 months</time_frame>
    <description>Measured by using data from the Norwegian Stroke Registry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistence</measure>
    <time_frame>1 year</time_frame>
    <description>Persistence measured by control of filled prescriptions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stroke and cardiovascular events and deaths</measure>
    <time_frame>1 year</time_frame>
    <description>Measured by using data from national health registries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>degree of disability or dependence in the daily activities</measure>
    <time_frame>1 year</time_frame>
    <description>measured by modified Rankin Scale and indirectly by level of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>1 year</time_frame>
    <description>Measured by using data from the Norwegian Stroke Registry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">265</enrollment>
  <condition>Ischemic Attack, Transient</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>drug use counselling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pharmacist conducting drug reconciliation, medication reviews and drug use counselling during hospitalisation. Follow up telephone calls 1 week, 1 month, 2 months and three months after discharge from hospital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patients in the control group receive no intervention just treatment and follow up according to national standards</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Drug use counselling</intervention_name>
    <arm_group_label>drug use counselling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Probable or possible transient ischemic attack

          -  Residing in Central Norway

          -  Examined within 2 weeks after the onset of symptoms

          -  Modified Rankin Scale 3 or less and living at home

          -  enrolled in the MIDNOR-TIA study NCT02038725

          -  Informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bent Indredavik, PhD, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kristiansund Sykehus</name>
      <address>
        <city>Kristiansund</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Levanger Sykehus</name>
      <address>
        <city>Levanger</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Molde Sykehus</name>
      <address>
        <city>Molde</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Namsos Sykehus</name>
      <address>
        <city>Namsos</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ålesund Sykehus</name>
      <address>
        <city>Ålesund</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.ntnu.no/inm/midnor-tia</url>
    <description>Related Info</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2014</study_first_submitted>
  <study_first_submitted_qc>March 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2014</study_first_posted>
  <last_update_submitted>March 29, 2017</last_update_submitted>
  <last_update_submitted_qc>March 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Secondary Prevention</keyword>
  <keyword>Pharmacists</keyword>
  <keyword>Directive Counseling</keyword>
  <keyword>Medication Adherence</keyword>
  <keyword>Patient Compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

